A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 262 participants.
Also called NCT02175784
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 262 participants
- Sponsor
- Registry
-
NCT02175784
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02175784. Randomized; quadruple masking; primary purpose treatment. Start 2014-03-31 (actual); primary completion 2015-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Intervention (Drug)
- placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct02175784- Content hash
ff140ecd10e044bacdc580cacf569b6859b278b4270d940efdbcf6d6ba7a0d1e